TNFR1 promoter -329G/T polymorphism results in allele-specific repression of TNFR1 expression

Biochemical and Biophysical Research Communications

Volumn 368, Issue 2, 2008, Pages 395-401

  Kim, Sun ^a   Moon, Song Mean ^b   Kim, Yong Sung ^c   Kim, Jae Jung ^a   Ryu, Ha Jung ^a   Kim, Yeon Jung ^b   Choi, Jung Won ^b   Park, Hong Seok ^c   Kim, Dae Ghon ^d   Shin, Hyoung Doo ^e   Rutherford, Mark S ^f   Oh, Bermseok ^b   Lee, Jong Keuk ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Korea National Institute of Health   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^d Chonbuk National University Medical School   (South Korea)

^e SNP Genetics Inc   (South Korea)

^f UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Hepatocellular carcinoma; Promoter; Single nucleotide polymorphism (SNP); TNFR1

Indexed keywords

GENOMIC DNA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1;

ALLELE; ARTICLE; CELL DEATH; CONTROLLED STUDY; DNA ISOLATION; GENE MUTATION; GENE REPRESSION; GENETIC POLYMORPHISM; HAPLOTYPE; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; LIVER CELL CARCINOMA; MULTIGENE FAMILY; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIVER NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I;

EID: 39649107976     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.01.098     Document Type: Article

References (27)

1. Murray C.J.L., and Lopez A.D. Mortality by cause for eight regions of the world. Lancet 349 (1997) 1269-1276
2. Thorgeirsson S.S., and Grisham J.W. Molecular pathogenesis of human hepatocellular carcinoma. Nat. Genet. 31 (2002) 339-346
3. Feitelson M.A., Sun B., Satiroglu Tufan N.L., Liu J., Pan J., and Lian Z. Genetic mechanisms of hepatocarcinogenesis. Oncogene 21 (2002) 2593-2604
4. Buendia M.A. Genetics of hepatocellular carcinoma. Semin. Cancer Biol. 10 (2000) 185-200
5. McGlynn K.A., Edmonson M.N., Michielli R.A., London W.T., Lin W.Y., Chen G.C., Shen F.M., and Buetow K.H. A phylogenetic analysis identifies heterogeneity among hepatocellular carcinomas. Hepatology 36 (2002) 1341-1348
6. Pikarsky E., Porat R.M., Stein I., Abramovitch R., Amit S., Kasem S., Gutkovich-Pyest E., Urieli-Shoval S., Galun E., and Ben-Neriah Y. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431 (2004) 461-466
7. Greten F.R., Eckmann L., Greten T.F., Park J.M., Li Z.-W., Egan L.J., Kagnoff M.F., and Karin M. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118 (2004) 285-296
8. Park J.G., Lee J.H., Kang M.S., Park K.J., Jeon Y.M., Lee H.J., Kwon H.S., Yeo K.S., and Lee K.U. Characterization of cell lines established from human hepatocellular carcinoma. Int. J. Cancer 62 (1995) 276-282
9. Lee J.H., Kang M.S., Ku J.L., Park Y.J., Lee K.U., Kim W.H., and Park J.G. Establishment and characterization of four human hepatocellular carcinoma cell lines containing hepatitis B virus DNA. World J. Gastroenterol. 5 (1999) 289-295
10. Rozen S., and Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S., and Misener S. (Eds). Bioinformatics Methods and Protocols: Methods in Molecular Biology (2000), Humana Press, Totowa, NJ 365-386
11. Nickerson D.A., Tobe V.O., and Taylor S.L. PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucleic Acids Res. 25 (1997) 2745-2751
12. Qin Z.S., Niu T., and Liu J.S. Partition-ligation-expectation-maximization algorithm for haplotype inference with single-nucleotide polymorphisms. Am. J. Hum. Genet. 71 (2002) 1242-1247
13. Sebastiani P., Lazarus R., Weiss S.T., Kunkel L.M., Kohane I.S., and Ramoni M.F. Minimal haplotype tagging. Proc. Natl. Acad. Sci. USA 100 (2003) 9900-9905
14. Clement M., Posada D., and Crandall K. TCS: a computer program to estimate gene genealogies. Mol. Ecology 9 (2000) 1657-1660
15. Locksley R.M., Killeen N., and Lenardo M.J. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104 (2001) 487-501
16. Aggarwal B.B. Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 3 (2003) 745-756
17. Kemper O., and Wallach D. Cloning and partial characterization of the promoter for the human p55 tumor necrosis factor (TNF) receptor. Gene 134 (1993) 209-216
18. Yan H., Dobbie Z., Gruber S.B., Markowitz S., Romans K., Giardiello F.M., Kinzler K.W., and Vogelstein B. Small changes in expression affect predisposition to tumorigenesis. Nat. Genet. 30 (2002) 25-26
19. Liedtke C., Plumpe J., Kubicka S., Bradham C.A., Manns M.P., Brenner D.A., and Trautwein C. Jun kinase modulates tumor necrosis factor-dependent apoptosis in liver cells. Hepatology 36 (2002) 315-325
20. Thiagalingam S., Foy R.L., Cheng K.H., Lee H.J., Thiagalingam A., and Ponte J.F. Loss of heterozygosity as a predictor to map tumor suppressor genes in cancer: molecular basis of its occurrence. Curr. Opin. Oncol. 14 (2002) 65-72
21. Balkwill F. Tumor necrosis factor or tumor promoting factor?. Cytokine Growth Factor Rev. 13 (2002) 135-141
22. Knight B., Yeoh G.C.T., Husk K.L., Ly T., Abraham L.J., Yu C., Rhim J.A., and Fausto N. Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice. J. Exp. Med. 192 (2000) 1809-1818
23. Filippova M., Song H., Connolly J.L., Dermody T.S., and Duerksen-Hughes P.J. The human papillomavirus 16E6 protein binds to tumor encrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis. J. Biol. Chem. 277 (2002) 21730-21739
24. Baillie J., Sahlender D.A., and Sinclair J.H. Human cytomegalovirus infection inhibits tumor necrosis factor alpha (TNF-a) signaling by targeting the 55-kilodalton TNF-a receptor. J. Virol. 77 (2003) 7007-7016
25. Morrison T.E., Mauser A., Klingelhutz A., and Kenney S.C. Epstein-Barr virus immediate-early protein BZLF1 inhibits tumor necrosis factor alpha-induced signaling and apoptosis by downregulating tumor necrosis factor receptor 1. J. Virol. 78 (2004) 544-549
26. McKall-Faienza K.J., Kawai K., Kundig T.M., Odermatt B., Bachmann M.F., Zakarian A., Mak T.W., and Ohashi P.S. Absence of TNFRp55 influences virus-induced autoimmunity despite efficient lymphocytic infiltration. Int. Immunol. 10 (1997) 405-412
27. Benedict C.A. Viruses and the TNF-related cytokines, an evolving battle. Cytokine Growth Factor Rev. 14 (2003) 349-357